WaferGen Q4 Revenues Rise Sharply With Increased SmartChip Sales | GenomeWeb

NEW YORK (GenomeWeb) - WaferGen Biosystems reported after the close of the market Tuesday that its fourth quarter 2015 revenues rose significantly year over year, driven by a 53 percent increase in product revenue, mainly from sales of its existing SmartChip products.

The company said revenues for Q4 2015 were 2.4 million, an increase of 50 percent compared to $1.6 million in the fourth quarter of 2014. The company's product revenues grew 53 percent overall to $2.3 million from about $1.5 million a year ago, while license and royalty revenues were flat at 125,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.